Parnell (AquaFOL, Pamlin, Ketamine, Methone, KEY and Imidox) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Buyout/​LBO
  • Financing Rounds
  • 1

Parnell (AquaFOL, Pamlin, Ketamine, Methone, KEY and Imidox) General Information

Description

Manufacturer of veterinary products. The company is engaged in producing medication which are primarily used for starting and maintaining anesthesia among pets in Australia.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Primary Office
  • PO Box 1035
  • Mascot, New South Wales 1460
  • Australia
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Parnell (AquaFOL, Pamlin, Ketamine, Methone, KEY and Imidox) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Parnell (AquaFOL, Pamlin, Ketamine, Methone, KEY and Imidox)‘s full profile, request access.

Request a free trial

Parnell (AquaFOL, Pamlin, Ketamine, Methone, KEY and Imidox) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Parnell (AquaFOL, Pamlin, Ketamine, Methone, KEY and Imidox)‘s full profile, request access.

Request a free trial